Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 1.85x is in line with its estimated 1-year average of 1.91x, around the middle of its estimated 1-year range (1.78x–2.01x).
As of 2026-10-06T19:12:35.350Z.
Calculation as of: 2026-10-06T19:12:35.350Z.
Quote observation: 2026-10-06T19:10:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 757805bafeebc6dd018a704dcae2ac70006cc574d7bdbc7e38b059e75a8ad8a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
1.85x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.41x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
-58.05%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.02B
EV/Sales Ratio
1.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
EV/Sales Ratio
31.91x
TTM Avg
409.08x
3Y Avg
413.14x
5Y Avg
302.30x
Market Cap
$1.02B
EV/Sales Ratio
2.79x
TTM Avg
2.39x
3Y Avg
2.22x
5Y Avg
3.30x
Market Cap
$1.03B
EV/Sales Ratio
1.73x
TTM Avg
1.75x
3Y Avg
2.13x
5Y Avg
2.79x
Market Cap
$1.01B
EV/Sales Ratio
N/A
TTM Avg
38.08x
3Y Avg
38.08x
5Y Avg
38.08x
Market Cap
$993.61M
EV/Sales Ratio
2.50x
TTM Avg
4.19x
3Y Avg
12.20x
5Y Avg
19.04x
Market Cap
$991.32M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.02B | 1.85x | N/A | N/A | N/A |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | 31.91x | 409.08x | 413.14x | 302.30x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 2.79x | 2.39x | 2.22x | 3.30x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 1.73x | 1.75x | 2.13x | 2.79x |
| Immatics N.V. (IMTX)vs › | $1.01B | 15.69x | 15.40x | 10.40x | 9.15x |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | 38.08x | 38.08x | 38.08x |
| Vor Biopharma Inc. (VOR)vs › | $999.21M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $993.61M | 2.50x | 4.19x | 12.20x | 19.04x |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $991.32M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | 0.53x | 0.60x | 0.81x | 2.06x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 1.86x |
| 2026-10-02 | 1.82x |
| 2026-10-01 | 1.80x |
| 2026-09-30 | 1.81x |
| 2026-09-29 | 1.81x |
| 2026-09-28 | 1.80x |
| 2026-09-25 | 1.81x |
| 2026-09-24 | 1.78x |
| 2026-09-23 | 1.80x |
| 2026-09-22 | 1.84x |
| 2026-09-21 | 1.85x |
| 2026-09-18 | 1.89x |
| 2026-09-17 | 1.93x |
| 2026-09-16 | 1.94x |
| 2026-09-15 | 1.95x |
| 2026-09-14 | 1.92x |
| 2026-09-11 | 1.93x |
| 2026-09-10 | 1.90x |
| 2026-09-09 | 1.91x |
| 2026-09-08 | 1.93x |
| 2026-09-04 | 1.99x |
| 2026-09-03 | 1.96x |
| 2026-09-02 | 1.95x |
| 2026-09-01 | 1.94x |
| 2026-08-31 | 1.94x |
| 2026-08-28 | 1.93x |
| 2026-08-27 | 1.95x |
| 2026-08-26 | 1.97x |
| 2026-08-25 | 1.98x |
| 2026-08-24 | 1.96x |
| 2026-08-21 | 2.01x |
| 2026-08-20 | 1.94x |
| 2026-08-19 | 1.96x |
| 2026-08-18 | 1.97x |
| 2026-08-17 | 1.95x |
| 2026-08-14 | 1.97x |
